Dafna Capital Management LLC Surface Oncology, Inc. Transaction History

Dafna Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.61 - $1.03 $193,370 - $326,510	317,000 Added 40.49%	1,100,000 $770,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $196,540 - $383,570	-317,000 Reduced 28.82%	783,000 $642,000
Q2 2022 Aug 15, 2022	BUY	$1.42 - $3.15 $596,400 - $1.32 Million	420,000 Added 61.76%	1,100,000 $1.8 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $5.08 $967,250 - $1.85 Million	365,000 Added 115.87%	680,000 $2 Million
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $1.49 Million - $2.49 Million	315,000 New	315,000 $1.51 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.